share_log

宜明昂科-B(01541)拟出售上海张投尧新科技发展全部股权

IMMUNEONCO-B (01541) plans to sell all of its equity in Shanghai Zhangtouyao New Technology Development.

Zhitong Finance ·  Dec 30, 2024 04:16

IMMUNEONCO-B (01541) announced that on December 30, 2024 (after trading hours), the company and...

According to the Zhito Finance App, IMMUNEONCO-B (01541) announced that on December 30, 2024 (after trading hours), the company entered into an agreement with the buyer Shanghai Zhangjiang (Group) Co., Ltd. and the target company Shanghai Zhangtouyao New Technology Development Co., Ltd., pursuant to which the company agrees to sell, and the buyer agrees to acquire all equity of the target company at a purchase price (maximum amount of 9,818.9 RMB minus adjustments).

The announcement stated that the company aims to achieve a more balanced and strategically aligned asset portfolio by entering into agreements regarding the sale, enhance capital utilization, and improve overall financial robustness. After the sale is realized, it will strengthen the group's cash flow, allowing the group to improve its liquidity position and reallocate resources for future development.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment